Skip to main content
. 2002 Jun 13;3:16. doi: 10.1186/1471-2091-3-16

Figure 5.

Figure 5

Relative increases in Ki for lerisetron, analog 1 and analog 2 on mutant and wildtype receptors. The relative change in Ki was determined as Ki (mutant)/ Ki (wildtype) for each compound. A. W89Y, W89F, R91A B. Y140A, Y142A, Y152A. Lerisetron showed a significant increase in Ki for all mutants except Y140A. Increases in Ki were observed for analog 1 and 2 on W89 and Y152A.

HHS Vulnerability Disclosure